These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26125969)

  • 21. Role of fidaxomicin for the treatment of Clostridium difficile infection.
    Juang P; Hardesty JS
    J Pharm Pract; 2013 Oct; 26(5):491-7. PubMed ID: 24064437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the MICs of fidaxomicin and other antibiotics against Hungarian Clostridium difficile isolates.
    Eitel Z; Terhes G; Sóki J; Nagy E; Urbán E
    Anaerobe; 2015 Feb; 31():47-9. PubMed ID: 25139122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of fidaxomicin for Clostridium difficile treatment.
    Simon MS
    Clin Infect Dis; 2014 Feb; 58(4):603. PubMed ID: 24300043
    [No Abstract]   [Full Text] [Related]  

  • 24. Fidaxomicin therapy in critically ill patients with Clostridium difficile infection.
    Penziner S; Dubrovskaya Y; Press R; Safdar A
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1776-81. PubMed ID: 25534722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin.
    Leeds JA; Sachdeva M; Mullin S; Barnes SW; Ruzin A
    J Antimicrob Chemother; 2014 Jan; 69(1):41-4. PubMed ID: 23887866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.
    Miller M
    Expert Opin Pharmacother; 2010 Jun; 11(9):1569-78. PubMed ID: 20446864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient approach to fluvirucins B2-B5, Sch 38518, and Sch 39185. First synthesis of their aglycon, via CM and RCM reactions.
    Llàcer E; Urpí F; Vilarrasa J
    Org Lett; 2009 Aug; 11(15):3198-201. PubMed ID: 19583204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Access to skipped polyene macrolides through ring-closing metathesis: total synthesis of the RNA polymerase inhibitor ripostatin B.
    Winter P; Hiller W; Christmann M
    Angew Chem Int Ed Engl; 2012 Apr; 51(14):3396-400. PubMed ID: 22337614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation, Structure, and Total Synthesis of the Marine Macrolide Mangrolide D.
    Gong J; Li W; Fu P; MacMillan J; De Brabander JK
    Org Lett; 2019 Apr; 21(8):2957-2961. PubMed ID: 30957503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile.
    Swanson RN; Hardy DJ; Shipkowitz NL; Hanson CW; Ramer NC; Fernandes PB; Clement JJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1108-11. PubMed ID: 1929250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward the synthesis of the antibiotic branimycin: novel approaches to highly substituted cis-decalin systems.
    Mulzer J; Castagnolo D; Felzmann W; Marchart S; Pilger C; Enev VS
    Chemistry; 2006 Aug; 12(23):5992-6001. PubMed ID: 16710867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States.
    Stranges PM; Hutton DW; Collins CD
    Value Health; 2013; 16(2):297-304. PubMed ID: 23538181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total synthesis of (+)-tubelactomicin A. 2. Synthesis of the upper-half segment and completion of the total synthesis.
    Motozaki T; Sawamura K; Suzuki A; Yoshida K; Ueki T; Ohara A; Munakata R; Takao K; Tadano K
    Org Lett; 2005 May; 7(11):2265-7. PubMed ID: 15901185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure.
    Chilton CH; Crowther GS; Freeman J; Todhunter SL; Nicholson S; Longshaw CM; Wilcox MH
    J Antimicrob Chemother; 2014 Feb; 69(2):451-62. PubMed ID: 24003182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total synthesis of the big four antibiotics and related antibiotics.
    Tatsuta K
    J Antibiot (Tokyo); 2013 Mar; 66(3):107-29. PubMed ID: 23532019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate-based macrolides prepared via a convergent ring closing metathesis approach: in search for novel antibiotics.
    Ruttens B; Blom P; Van Hoof S; Hubrecht I; Van der Eycken J; Sas B; Van Hemel J; Vandenkerckhove J
    J Org Chem; 2007 Jul; 72(15):5514-22. PubMed ID: 17583955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total synthesis of 13-demethyllyngbyaloside B.
    Fuwa H; Yamagata N; Saito A; Sasaki M
    Org Lett; 2013 Apr; 15(7):1630-3. PubMed ID: 23472842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance.
    Kufel WD; Hitchcock AM; Delbalso AN; Paolino KM
    J Antimicrob Chemother; 2023 Apr; 78(4):1127-1128. PubMed ID: 36790902
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives.
    Zhang SJ; Yang Q; Xu L; Chang J; Sun X
    Bioorg Med Chem Lett; 2012 Aug; 22(15):4942-5. PubMed ID: 22765891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.